NPAT (Nuclear Protein, Coactivator of Histone Transcription) inhibitors are a class of chemical compounds designed to target and inhibit the activity of NPAT, a key protein involved in the regulation of histone gene transcription. NPAT is a nuclear protein that functions primarily in cell cycle progression and chromatin organization, playing a crucial role in histone gene transcription during the S-phase of the cell cycle. It acts as a coactivator, coordinating the transcription of histones required for chromatin assembly and DNA replication. NPAT is associated with nuclear structures called Histone Locus Bodies (HLBs), where it regulates the transcription of histone gene clusters. The inhibition of NPAT leads to the disruption of histone mRNA synthesis, affecting chromatin structure and cellular processes such as DNA replication and cell division.
NPAT inhibitors generally work by binding to the NPAT protein or interfering with its associated signaling pathways, thereby preventing its interaction with other co-factors or its ability to promote histone transcription. Such inhibition disrupts the coordinated expression of histone genes, leading to downstream effects on chromatin organization and cellular replication. By targeting the NPAT pathway, these inhibitors provide valuable tools for studying the intricate regulation of cell cycle progression and chromatin dynamics. The molecular diversity of NPAT inhibitors can vary widely, encompassing small molecules, peptides, or other chemical scaffolds, each uniquely affecting NPAT activity or its interactions. These inhibitors serve as important research tools for understanding the regulation of histone gene transcription and the broader implications for cellular growth and chromatin function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
A cyclin-dependent kinase (CDK) inhibitor that can affect the cell cycle and potentially impact NPAT function. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Another CDK inhibitor, known to target various cyclin-dependent kinases involved in cell cycle regulation, potentially influencing NPAT activity. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
A PARP inhibitor, which, while primarily used in DNA repair pathways, could indirectly affect NPAT function due to its role in the S phase of the cell cycle. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, which can alter chromatin structure and potentially impact NPAT-mediated histone transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Also a histone deacetylase inhibitor, it can indirectly affect NPAT activity by altering chromatin accessibility and histone modifications. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A specific inhibitor of CDK4 and CDK6, which may indirectly impact NPAT's role in cell cycle progression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, it's a DNA methyltransferase inhibitor that may indirectly affect NPAT's function in histone gene transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
An inhibitor of Topoisomerase I, impacting DNA replication and potentially influencing the activity of NPAT in the S phase. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can affect various cellular processes, including those regulated by NPAT. | ||||||